abstract |
Abstract The present invention provides stabilized activin IB receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF- 11. The present invention also provides polynucleotides, vectors and host cells capable of 5 producing the stabilized polypeptides and proteins. Compositions and methods for treating muscle-wasting diseases and metabolic disorders are also provided. |